Genfit(GNFT) - 2023 Q4 - Annual Report

Exhibit 99.1 GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F GENFIT's 2023 Universal Registration Document includes, in particular: ABOUT GENFIT GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanni ...